Clinical Trials Browser

Phase 2 × OTHER × Solid Cancers × Clear all

NCT07170293 2025-09-12

Phase II Trial of Tunlametinib in Patients With NRAS Mutant Non-melanoma Refractory Solid Tumors

Phase 2 Recruiting

Solid Cancers